CA2359958C - Process for preparing 1-(6-methylpyridin-3yl)-2-[(4-methylsulfonyl)phenyl]ethanone - Google Patents
Process for preparing 1-(6-methylpyridin-3yl)-2-[(4-methylsulfonyl)phenyl]ethanone Download PDFInfo
- Publication number
- CA2359958C CA2359958C CA002359958A CA2359958A CA2359958C CA 2359958 C CA2359958 C CA 2359958C CA 002359958 A CA002359958 A CA 002359958A CA 2359958 A CA2359958 A CA 2359958A CA 2359958 C CA2359958 C CA 2359958C
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- methylpyridin
- formula
- process according
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
Abstract
1-(6-Methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone of the formula (see formula I) and a process for preparing such is disclosed. 1-(6-Methylpyridin-3- yl)-2-[(4-(methylsulfonyl)phenyl]ethanone is an important intermediate for preparing so-called COX-2 inhibitors, which are pharmaceutically active compounds having analgesic and anti-inflammatory action .
Description
Description The invention comprises a novel process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]-ethanone of the formula SOZCH~
io (I) 1-(6-Methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]-ethanone is an important intermediate for preparing so-called COX-2 inhibitors, which are pharmaceutically active compounds having analgesic and anti-inflammatory action (R. S. Friesen et al., Bioorganic & Medicinal Chemistry Letters 8 (1998) 2777-2782; WO 98/03484). 1-(6-Methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone of the formula (I) is a novel compound which is not known from the literature.
It is an object of the invention to provide a novel intermediate for the production of COX-2 inhibitors and to provide an industrially feasible process for preparing the intermediate of the formula (I).
Accordingly, as an aspect of the invention, there is provided a process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone of the formula -la-(I) wherein 2-methyl-5-vinylpyridine is initially converted, by reaction with ozone and subsequent reduction, into 2-methylpyridine-5-carbaldehyde or into 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid or acid salt of the formula SOC M~
(II) in which M is an alkali metal, which is then reacted with a dialkylamine and a cyano compound to give a N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile of the f ormula ~ R' 3o r'~~~Rz (III) -lb-in which R1 and Rz are identical or different and are each C1_4-alkyl, and the acetonitrile (III) is finally reacted, in the presence of a base, with a 4-(methylsulfonyl)benzyl halide to give 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]-ethanone of the formula (I).
As another aspect, the invention provides a 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt of the formula OH
SO~ ~i~
(II) in which M is an alkali metal.
A further aspect of the invention provides a process for preparing a 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt as defined herein, wherein 2-methyl-5-vinylpyridine is converted, by reaction with ozone and subsequent reduction with an alkali metal hydrogen sulfite, into the end product of the formula (II) .
Yet another aspect of the invention provides a process for preparing a N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile of the formula (III) R' T
Ir_\RZ
C i~
(III) in which R1 and R2 are identical or different and are each C1_4-alkyl, wherein 2-methylpyridine-5-carbaldehyde or 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt of the formula (II) H
SOCM~
(II) is reacted with a dialkylamine and a cyano compound to give the end product of the formula (III).
Finally, the invention also provides a process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone of the formula 3 o S01CH3 (I) -ld-wherein in a first step a), 2-methyl-5-ethylpyridine is converted at a temperature of from 500°C to 700°C in the presence of a catalyst into 2-methyl-5-vinylpyridine, in a second step b), the 2-methyl-5-vinylpyrdine is converted by reaction with ozone and subsequent reduction into 2-methylpyridine-5-carbaldehyde, in a third step c), 2-methylpyridine-5-carbaldehyde is converted, using a dialkylamine and a cyano compound, into the corresponding N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile, and finally, in a last step d), the N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile is reacted in the presence of a base with a 4-(methylsulfonyl)benzyl halide to give 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone.
The process according to the invention comprises four steps, where in the first step a) 2-methyl-5-ethylpyridine is converted at from 500°C to 700°C in the presence of a catalyst into 2-methyl-5-vinylpyridine, in the second step b) the 2-methyl-5-vinylpyridine is converted with ozone and subsequent reductive work-up into 2-methylpyridin-5-carbaldehyde, in the third step c) the 2-methylpyridin-5-carbaldehyde is converted with a dialkylamine and a CN
compound into the corresponding N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile and finally in the last step d) the N,N,-dialkylamino-(6-methyl-3-pyridyl)acetonitrile is reacted in the presence of a base with a 4-(methylsulfonyl)benzyl halide to give 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone to give the end product.
A considerable advantage of the process according to the invention consists in the fact that industrially available 2-methyl-5-ethylpyridine can be used as starting material.
Step a:
The dehydration of 2-methyl-5-ethylpyridine to give 2-methyl-5-vinylpyridine is known from the literature (for example A. Nenz et al., Hydrocarbon Processing, 47 (11) , 196$, 139-144; US-A 2,769, 773) .
The reaction proceeds at from 500°C to 700°C in the presence of a large number of different catalysts.
In general, catalysts based on silica, silica gel, iron oxide, zinc oxide, chromium oxide, copper chromite, magnesium oxide, potassium oxide, alumina or boron phosphate, alone or as a mixture, if appropriate applied to a support, are employed.
Good results can be obtained inter alia with a zinc oxide catalyst applied to pumice as support.
It is furthermore advantageous for the reaction to dilute the 2-methylpyridine with steam or an inert gas, but preferably with steam.
The 2-methyl-5-vinylpyridine can be purified in a simple manner, for example by removal of the aqueous phase and subsequent steam distillation or vakuum distillation, such that it is suitable for the subsequent step b).
Step b:
The reaction with ozone is advantageously carried out in the presence of a mineral acid at a temperature of from -20°C to 0°C, preferably at a temperature of from -15°C to -5°C. Suitable mineral acids are sulfuric acid or phosphoric acid, and in particular sulfuric acid. Suitable reaction media are water and/or a polar solvent. As a polar solvent C1_6 alcohols can be used such as methanol, ethanol, propanol, butanol, pentanol or hexanol. Mixtures of a lower alcohol, such as methanol or ethanol, with water have been found to be useful.
The ozone complex which is formed as an intermediate is worked up reductively, preferably with an alkali metal hydrogen sulphite, to obtain the 2-methyl-5-carbaldehyde.
Suitable alkali metal hydrogen sulphites are sodium or 15. potassium hydrogen sulphite. However, it is also possible to choose other known reducing agents, such as, for example, dimethyl sulphide, thiourea or trimethyl phosphite, or hydrogen in the presence of a suitable catalyst.
In the case of the preferred reductive work-up with alkali metal hydrogen sulphite, the reaction is carried out in essentially the same medium as used for the ozonization, generally at a temperature of from -20°C to 20°C, preferably from -10°C to 0°C.
Depending on the further work-up steps, the 2-methylpyridine-5-carbaldehyde or an adduct of alkali metal hydrogen sulphite with the 2-methylpyridine-5-carbaldehyde can be formed.
If it is desired to isolate t=he 2-methyl-5 carbaldehyde, it is possible to selectively extract the reaction mixture at a pH of about ~ to 5 with a suitable organic solvent, such as, foz: example, with ethyl acetate. Alternatively, but preferred, an adduct of alkali metal hydrogen sulphite with the 2-methylpyridine-5-carbaldehyde may be formed initially, which is then cleaved at a pH of about 10 into the 2-methyl-5-carbaldehyde.
Particularly preferably, however, the adduct of alkali metal hydrogen sulphite with the 2-methyl-pyridine-5-carbaldehyde is employed immediately for further reaction in step c). Thus, it is possible to circumvent isolation of the relatively unstable 2-methylpyridine-5-carbaldehyde in an elegant manner.
The adduct of alkali metal hydrogen sulphite with the 2-methylpyridine-5-carbaldehyde is novel and not known from the literature and accordingly also part of the subject-matter of the invention. The adducts have the general formula O~I
/ ~ ~SOOMO+ (II) in which M is an alkali metal, and are referred to as 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salts. The alkali metal M is advantageously Na or K.
Step c:
The reaction of the 2-methylpyridine-5-carbaldehyde or the adduct of alkali metal hydrogen sulphite with the 2-methylpyridine-5-carbaldehyde is carried out according to the principle of the Strecker synthesis using a CN compound and a dialkylamine to give the corresponding N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile.
An aqueous HCN solution or an aqueous solution of an alkali metal cyanide may serve as CN compound here. A
suitable dialkylamine is a C1_4-dialkylamine, in particular dimethylamine or diethylamine.
The reaction temperature is advantageously in the range of from 0°C to 30°C.
It may be advantageous to add a water-immiscible solvent, such as, for example, toluene or t-butyl methyl ether. Work-up and isolation of the corresponding N,N-dialkylamino-(6-methyl-3-pyridyl)-acetonitrile can then be carried out by simple phase separation. The N,N-dialkylamino-(6-methyl-3-pyridyl)-acetonitriles of the general formula N(Alk)a (III) N
in which Alk is an alkyl group of from 1 to 4 carbon atoms are novel compounds which are not known from the literature, and they therefore also form part of the subject-matter of the invention.
Alkyl is specifically methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl or tert-butyl. The preferred meaning of Alk is methyl or ethyl.
Step d:
The conversion of the N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile by reaction with the 4-(methylsulfonyl) benzyl halide to give the end product of the formula I is carried out in the presence of a base. A suitable 4-(methylsulfonyl)benzyl halide is 4-(methylsulfonyl)benzyl chloride.
The base used can be an aqueous alkali metal hydroxide solution, preferably an aqueous sodium hydroxide solution, where in this case the presence of a customary phase-transfer catalyst is useful. Suitable phase-transfer catalysts are, for example, tetraalkylammonium halides, such as, for example, tetra-n-butylammonium chloride or tetra-n-butylammonium bromide. The reaction temperature is in the range of from 40°C to 70°C. It may be advantageous to add a water-immiscible solvent, such as, for example, toluene, methylene chloride or t-butyl methyl ether.
Alternatively and preferably, the base used is an alkali metal alkoxide. Suitable alkali metal alkoxides are, for example, sodium tert-butoxide, potassium tert-butoxide or sodium tert-pentoxide, and preferably potassium tert-butoxide. Recommended solvents are ethers, such as, for example, tetrahydrofuran. The reaction temperature in this variant is generally from 15°C to 25°C.
T he 1- ( 6-methylpyridiri-3-yl ) -2- ( ( 4 - (me thyl sulfonyl)phenyl)ethanone can be isolated in a manner known to the person skilled in the art, for example by acidifying the reaction mixture, followed by extraction with, for example, toluene. Further purification can be carried out by recrystallization, for example in acetonitrile.
Example 1 Preparation of 2-methyl-5-vinylpyridine Pumice having a particle size of from 6 to 8 mm is moistened with water and mixed with 25% of its dry weight of zinc oxide in powder form, filled moist into the reactor (length of the tube 750 mm, diameter of the tube 60 mm) and left in a stream of nitrogen at from 650°C to 700°C for 24 h.
?6 ml/h of 2-methyl-5-ethylpyridine together with 87 ml/h of steam were passed over the abovementioned catalyst at from 670°C to 680°C and 665 mbar. At the end of the reactor, a product stream consisting of 40.6% by weight of 2-methyl-5-vinylpyridine and 56.3%
of 2-methyl-5-ethylpyridine was taken off. Based on reacted 2-methyl-5-ethylpyridine, a yield of 93.Oo was achieved.
To prepare pure 2-methyl-5-vinylpyridine, the product mixture was subsequently subjected to steam distillation (266 mbar, overhead temperature 59°C-60°C) or to vacuum distillation (20 mbar, temperature 90 °C) .
Example 2 Preparation of 2-methylpyridine-5-carbaldehyde 11.92 g of 2-methyl-5-vinylpyridine (content 85%, 85 mmol),, 50 ml of methanol and 10 ml of water were initially charged. Concentrated sulphuric acid (9.81 g, 98 mmol) was metered in such that the temperature did not exceed 20°C. The solution was _ 7 cooled from -12°C and an ozone/oxygen mixture (about 50 03 in 02, 50 1/h) was introduced until the 2-methyl-5-vinylpyridine had reacted completely. Water (50 ml) and 40o aqueous NaHS03 solution (22.7 g, 85 mmol) were carefully metered in. The reaction mixture was warmed to 20°C and neutralized using 30% NaOH (about 32 g, 0.24 mol). Methanol was distilled off at 30-40°C, and then, to form the bisulphite adduct, another 22.7 g of 40o NaHS03 solution were added. The mixture was stirred for 30 min, after which the pH was readjusted to neutral, and the neutral impurities were subsequently extracted using 35 ml of t-butyl methyl ether. The aqueous phase was adjusted to pH 10 using 30o NaOH, and 26.5 g of Na2C03 (0.25 mol) were added. The liberated aldehyde was extracted using 2 x 80 ml of t-butyl methyl ether. Concentration of the solvent gave 9 g of 2-methylpyridine-5-carbaldehyde as a slightly yellowish oil.
1H-NMR (CDC13): 2.66 (s, 3H);
io (I) 1-(6-Methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]-ethanone is an important intermediate for preparing so-called COX-2 inhibitors, which are pharmaceutically active compounds having analgesic and anti-inflammatory action (R. S. Friesen et al., Bioorganic & Medicinal Chemistry Letters 8 (1998) 2777-2782; WO 98/03484). 1-(6-Methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone of the formula (I) is a novel compound which is not known from the literature.
It is an object of the invention to provide a novel intermediate for the production of COX-2 inhibitors and to provide an industrially feasible process for preparing the intermediate of the formula (I).
Accordingly, as an aspect of the invention, there is provided a process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone of the formula -la-(I) wherein 2-methyl-5-vinylpyridine is initially converted, by reaction with ozone and subsequent reduction, into 2-methylpyridine-5-carbaldehyde or into 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid or acid salt of the formula SOC M~
(II) in which M is an alkali metal, which is then reacted with a dialkylamine and a cyano compound to give a N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile of the f ormula ~ R' 3o r'~~~Rz (III) -lb-in which R1 and Rz are identical or different and are each C1_4-alkyl, and the acetonitrile (III) is finally reacted, in the presence of a base, with a 4-(methylsulfonyl)benzyl halide to give 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]-ethanone of the formula (I).
As another aspect, the invention provides a 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt of the formula OH
SO~ ~i~
(II) in which M is an alkali metal.
A further aspect of the invention provides a process for preparing a 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt as defined herein, wherein 2-methyl-5-vinylpyridine is converted, by reaction with ozone and subsequent reduction with an alkali metal hydrogen sulfite, into the end product of the formula (II) .
Yet another aspect of the invention provides a process for preparing a N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile of the formula (III) R' T
Ir_\RZ
C i~
(III) in which R1 and R2 are identical or different and are each C1_4-alkyl, wherein 2-methylpyridine-5-carbaldehyde or 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt of the formula (II) H
SOCM~
(II) is reacted with a dialkylamine and a cyano compound to give the end product of the formula (III).
Finally, the invention also provides a process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone of the formula 3 o S01CH3 (I) -ld-wherein in a first step a), 2-methyl-5-ethylpyridine is converted at a temperature of from 500°C to 700°C in the presence of a catalyst into 2-methyl-5-vinylpyridine, in a second step b), the 2-methyl-5-vinylpyrdine is converted by reaction with ozone and subsequent reduction into 2-methylpyridine-5-carbaldehyde, in a third step c), 2-methylpyridine-5-carbaldehyde is converted, using a dialkylamine and a cyano compound, into the corresponding N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile, and finally, in a last step d), the N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile is reacted in the presence of a base with a 4-(methylsulfonyl)benzyl halide to give 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone.
The process according to the invention comprises four steps, where in the first step a) 2-methyl-5-ethylpyridine is converted at from 500°C to 700°C in the presence of a catalyst into 2-methyl-5-vinylpyridine, in the second step b) the 2-methyl-5-vinylpyridine is converted with ozone and subsequent reductive work-up into 2-methylpyridin-5-carbaldehyde, in the third step c) the 2-methylpyridin-5-carbaldehyde is converted with a dialkylamine and a CN
compound into the corresponding N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile and finally in the last step d) the N,N,-dialkylamino-(6-methyl-3-pyridyl)acetonitrile is reacted in the presence of a base with a 4-(methylsulfonyl)benzyl halide to give 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone to give the end product.
A considerable advantage of the process according to the invention consists in the fact that industrially available 2-methyl-5-ethylpyridine can be used as starting material.
Step a:
The dehydration of 2-methyl-5-ethylpyridine to give 2-methyl-5-vinylpyridine is known from the literature (for example A. Nenz et al., Hydrocarbon Processing, 47 (11) , 196$, 139-144; US-A 2,769, 773) .
The reaction proceeds at from 500°C to 700°C in the presence of a large number of different catalysts.
In general, catalysts based on silica, silica gel, iron oxide, zinc oxide, chromium oxide, copper chromite, magnesium oxide, potassium oxide, alumina or boron phosphate, alone or as a mixture, if appropriate applied to a support, are employed.
Good results can be obtained inter alia with a zinc oxide catalyst applied to pumice as support.
It is furthermore advantageous for the reaction to dilute the 2-methylpyridine with steam or an inert gas, but preferably with steam.
The 2-methyl-5-vinylpyridine can be purified in a simple manner, for example by removal of the aqueous phase and subsequent steam distillation or vakuum distillation, such that it is suitable for the subsequent step b).
Step b:
The reaction with ozone is advantageously carried out in the presence of a mineral acid at a temperature of from -20°C to 0°C, preferably at a temperature of from -15°C to -5°C. Suitable mineral acids are sulfuric acid or phosphoric acid, and in particular sulfuric acid. Suitable reaction media are water and/or a polar solvent. As a polar solvent C1_6 alcohols can be used such as methanol, ethanol, propanol, butanol, pentanol or hexanol. Mixtures of a lower alcohol, such as methanol or ethanol, with water have been found to be useful.
The ozone complex which is formed as an intermediate is worked up reductively, preferably with an alkali metal hydrogen sulphite, to obtain the 2-methyl-5-carbaldehyde.
Suitable alkali metal hydrogen sulphites are sodium or 15. potassium hydrogen sulphite. However, it is also possible to choose other known reducing agents, such as, for example, dimethyl sulphide, thiourea or trimethyl phosphite, or hydrogen in the presence of a suitable catalyst.
In the case of the preferred reductive work-up with alkali metal hydrogen sulphite, the reaction is carried out in essentially the same medium as used for the ozonization, generally at a temperature of from -20°C to 20°C, preferably from -10°C to 0°C.
Depending on the further work-up steps, the 2-methylpyridine-5-carbaldehyde or an adduct of alkali metal hydrogen sulphite with the 2-methylpyridine-5-carbaldehyde can be formed.
If it is desired to isolate t=he 2-methyl-5 carbaldehyde, it is possible to selectively extract the reaction mixture at a pH of about ~ to 5 with a suitable organic solvent, such as, foz: example, with ethyl acetate. Alternatively, but preferred, an adduct of alkali metal hydrogen sulphite with the 2-methylpyridine-5-carbaldehyde may be formed initially, which is then cleaved at a pH of about 10 into the 2-methyl-5-carbaldehyde.
Particularly preferably, however, the adduct of alkali metal hydrogen sulphite with the 2-methyl-pyridine-5-carbaldehyde is employed immediately for further reaction in step c). Thus, it is possible to circumvent isolation of the relatively unstable 2-methylpyridine-5-carbaldehyde in an elegant manner.
The adduct of alkali metal hydrogen sulphite with the 2-methylpyridine-5-carbaldehyde is novel and not known from the literature and accordingly also part of the subject-matter of the invention. The adducts have the general formula O~I
/ ~ ~SOOMO+ (II) in which M is an alkali metal, and are referred to as 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salts. The alkali metal M is advantageously Na or K.
Step c:
The reaction of the 2-methylpyridine-5-carbaldehyde or the adduct of alkali metal hydrogen sulphite with the 2-methylpyridine-5-carbaldehyde is carried out according to the principle of the Strecker synthesis using a CN compound and a dialkylamine to give the corresponding N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile.
An aqueous HCN solution or an aqueous solution of an alkali metal cyanide may serve as CN compound here. A
suitable dialkylamine is a C1_4-dialkylamine, in particular dimethylamine or diethylamine.
The reaction temperature is advantageously in the range of from 0°C to 30°C.
It may be advantageous to add a water-immiscible solvent, such as, for example, toluene or t-butyl methyl ether. Work-up and isolation of the corresponding N,N-dialkylamino-(6-methyl-3-pyridyl)-acetonitrile can then be carried out by simple phase separation. The N,N-dialkylamino-(6-methyl-3-pyridyl)-acetonitriles of the general formula N(Alk)a (III) N
in which Alk is an alkyl group of from 1 to 4 carbon atoms are novel compounds which are not known from the literature, and they therefore also form part of the subject-matter of the invention.
Alkyl is specifically methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl or tert-butyl. The preferred meaning of Alk is methyl or ethyl.
Step d:
The conversion of the N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile by reaction with the 4-(methylsulfonyl) benzyl halide to give the end product of the formula I is carried out in the presence of a base. A suitable 4-(methylsulfonyl)benzyl halide is 4-(methylsulfonyl)benzyl chloride.
The base used can be an aqueous alkali metal hydroxide solution, preferably an aqueous sodium hydroxide solution, where in this case the presence of a customary phase-transfer catalyst is useful. Suitable phase-transfer catalysts are, for example, tetraalkylammonium halides, such as, for example, tetra-n-butylammonium chloride or tetra-n-butylammonium bromide. The reaction temperature is in the range of from 40°C to 70°C. It may be advantageous to add a water-immiscible solvent, such as, for example, toluene, methylene chloride or t-butyl methyl ether.
Alternatively and preferably, the base used is an alkali metal alkoxide. Suitable alkali metal alkoxides are, for example, sodium tert-butoxide, potassium tert-butoxide or sodium tert-pentoxide, and preferably potassium tert-butoxide. Recommended solvents are ethers, such as, for example, tetrahydrofuran. The reaction temperature in this variant is generally from 15°C to 25°C.
T he 1- ( 6-methylpyridiri-3-yl ) -2- ( ( 4 - (me thyl sulfonyl)phenyl)ethanone can be isolated in a manner known to the person skilled in the art, for example by acidifying the reaction mixture, followed by extraction with, for example, toluene. Further purification can be carried out by recrystallization, for example in acetonitrile.
Example 1 Preparation of 2-methyl-5-vinylpyridine Pumice having a particle size of from 6 to 8 mm is moistened with water and mixed with 25% of its dry weight of zinc oxide in powder form, filled moist into the reactor (length of the tube 750 mm, diameter of the tube 60 mm) and left in a stream of nitrogen at from 650°C to 700°C for 24 h.
?6 ml/h of 2-methyl-5-ethylpyridine together with 87 ml/h of steam were passed over the abovementioned catalyst at from 670°C to 680°C and 665 mbar. At the end of the reactor, a product stream consisting of 40.6% by weight of 2-methyl-5-vinylpyridine and 56.3%
of 2-methyl-5-ethylpyridine was taken off. Based on reacted 2-methyl-5-ethylpyridine, a yield of 93.Oo was achieved.
To prepare pure 2-methyl-5-vinylpyridine, the product mixture was subsequently subjected to steam distillation (266 mbar, overhead temperature 59°C-60°C) or to vacuum distillation (20 mbar, temperature 90 °C) .
Example 2 Preparation of 2-methylpyridine-5-carbaldehyde 11.92 g of 2-methyl-5-vinylpyridine (content 85%, 85 mmol),, 50 ml of methanol and 10 ml of water were initially charged. Concentrated sulphuric acid (9.81 g, 98 mmol) was metered in such that the temperature did not exceed 20°C. The solution was _ 7 cooled from -12°C and an ozone/oxygen mixture (about 50 03 in 02, 50 1/h) was introduced until the 2-methyl-5-vinylpyridine had reacted completely. Water (50 ml) and 40o aqueous NaHS03 solution (22.7 g, 85 mmol) were carefully metered in. The reaction mixture was warmed to 20°C and neutralized using 30% NaOH (about 32 g, 0.24 mol). Methanol was distilled off at 30-40°C, and then, to form the bisulphite adduct, another 22.7 g of 40o NaHS03 solution were added. The mixture was stirred for 30 min, after which the pH was readjusted to neutral, and the neutral impurities were subsequently extracted using 35 ml of t-butyl methyl ether. The aqueous phase was adjusted to pH 10 using 30o NaOH, and 26.5 g of Na2C03 (0.25 mol) were added. The liberated aldehyde was extracted using 2 x 80 ml of t-butyl methyl ether. Concentration of the solvent gave 9 g of 2-methylpyridine-5-carbaldehyde as a slightly yellowish oil.
1H-NMR (CDC13): 2.66 (s, 3H);
7.35 (d, J = 8 Hz, 1H);
8.07 (dd, J = 8 Hz and 2.1 Hz, 1H);
8.96 (d, J = 2.1 Hz, 1H);
10.08 (s, 1H).
i3C-NMR (CDC13): 24.98 (CH3);
123.72 (C-5);
129.32 (C-3);
135.88 (C-4);
151.87 (C-2);
164.87 (C-6);
190.51 (C=0).
Example 3a.
Preparation of N,N-diethylamino-(6-methylpyridin-3-yl)acetonitrile (from 2-methylpyridine-5-carbaldehyde) At from 10°C to 15°C, 73.2 g (1.25 eq.) of diethylamine and 100.3 g (1.15 eq.) of a 25o HCN
solution were added simultaneously over a period of one S, hour to a mixture of 98.3 g (1.0 eq.) of 2-methylpyridine-5-carbaldehyde in 200 ml of water and 200 ml of toluene which was stirred efficiently. The reaction mixture was stirred at 30°C for 3 h.
The phases were then separated and the aqueous phase was extracted with 2 x 100 ml of toluene. The organic phases were combined and the toluene was then removed, giving the title product in the form of a yellowish oil and in a yield of 172.3 g (90.10).
1H-NMR (CDC13) : 8.65 (1H, s) ;
7.75 (1H, d);
7 . 20 ( d) 1H, ;
5.00 (1H, s);
2. 68 (2H, m) ;
2.59 (13H,s);
2. 50 (2H, m) ;
1.10 (6H, t).
1H-NMR (D6-DMSO): 8.50 (1H,s);
7.70 (1H,d);
7.32 (1H,d);
5.45 (1H,s);
2.58 (2H,m);
2.50 (3H,s);
2.40 (2H,m);
1.02 (6H,t).
Example 3b.
Preparation of N,N-diethylamino-(6-methylpyridin-3 yl)acetonitrile (via the adduct of 2-methylpyridine-5 carbaldehyde with sodium hydrogen sulphite) The ozonolysis was carried out as in Example 2, starting from 23.84 g of 2-methyl-5-vinylpyridine (83.10 GC, 166.2 mmol). After the impurities had been extracted at neutral pH, the aqueous phase was cooled to 15°C and diethylamine (21.94 g, 0.3 mol) and then 9.8 g of NaCN (0.2 mol) were added (in each case addition over a period of 10 min). The solution was _ g _ stirred at 15°C for 4.5 h, and the product was subsequently extracted with 3 x 85 ml of toluene. The combined extracts were concentrated. Obtained: 37.4 g of N,N-diethylamino-(6-methylpyridin-3-yl)acetonitrile as an orange oil. Content: 83.70 (GC, o by weight), 0.340 of aldehyde). Yield: 92.70 based on 2-methyl-5-vinylpyridine.
1H-NMR (CDC13) : 1. 08 (t, 6H) ;
2.50 (m, 2H);
2.58 (s, 3H);
2.65 (m, 2H);
5.00 (s, 1H);
7.18 (d, J = 8 Hz, 1H);
7.74 (dd,J = 8 Hz, 2 Hz, 1H);
8.66 (d, J = 2 Hz, 1:H) .
Example 3c.
Preparation and characterization of the adduct of 2-methylpyridine-5-carbaldehyde with sodium hydrogen sulphite After the addition of bisulphate, the 1H- and 13C-NMR of a sample were measured. The NMR signals of the aldehyde had disappeared completely, and the following signals were observed instead:
1H-NMR (DMSO-d6): 1.96 (s, 3H);
5.01 (s, 1H) ;
6.85 (d, J = 8 Hz, 1H);
7.45 (dd, J = 8 and 2 Hz, 1H);
7. 93 (d, J = 2 Hz, 1H) .
1sC-NMR ( DMSO-d6 ) : 2 0 . 2 3 ( CH3 ) ;
81.78 (CH);
124. 14 (C-5) ;
130.02 (C-3) ;
138.76 (C-4);
143.08 (C-2);
156.04 (C-6).
8.96 (d, J = 2.1 Hz, 1H);
10.08 (s, 1H).
i3C-NMR (CDC13): 24.98 (CH3);
123.72 (C-5);
129.32 (C-3);
135.88 (C-4);
151.87 (C-2);
164.87 (C-6);
190.51 (C=0).
Example 3a.
Preparation of N,N-diethylamino-(6-methylpyridin-3-yl)acetonitrile (from 2-methylpyridine-5-carbaldehyde) At from 10°C to 15°C, 73.2 g (1.25 eq.) of diethylamine and 100.3 g (1.15 eq.) of a 25o HCN
solution were added simultaneously over a period of one S, hour to a mixture of 98.3 g (1.0 eq.) of 2-methylpyridine-5-carbaldehyde in 200 ml of water and 200 ml of toluene which was stirred efficiently. The reaction mixture was stirred at 30°C for 3 h.
The phases were then separated and the aqueous phase was extracted with 2 x 100 ml of toluene. The organic phases were combined and the toluene was then removed, giving the title product in the form of a yellowish oil and in a yield of 172.3 g (90.10).
1H-NMR (CDC13) : 8.65 (1H, s) ;
7.75 (1H, d);
7 . 20 ( d) 1H, ;
5.00 (1H, s);
2. 68 (2H, m) ;
2.59 (13H,s);
2. 50 (2H, m) ;
1.10 (6H, t).
1H-NMR (D6-DMSO): 8.50 (1H,s);
7.70 (1H,d);
7.32 (1H,d);
5.45 (1H,s);
2.58 (2H,m);
2.50 (3H,s);
2.40 (2H,m);
1.02 (6H,t).
Example 3b.
Preparation of N,N-diethylamino-(6-methylpyridin-3 yl)acetonitrile (via the adduct of 2-methylpyridine-5 carbaldehyde with sodium hydrogen sulphite) The ozonolysis was carried out as in Example 2, starting from 23.84 g of 2-methyl-5-vinylpyridine (83.10 GC, 166.2 mmol). After the impurities had been extracted at neutral pH, the aqueous phase was cooled to 15°C and diethylamine (21.94 g, 0.3 mol) and then 9.8 g of NaCN (0.2 mol) were added (in each case addition over a period of 10 min). The solution was _ g _ stirred at 15°C for 4.5 h, and the product was subsequently extracted with 3 x 85 ml of toluene. The combined extracts were concentrated. Obtained: 37.4 g of N,N-diethylamino-(6-methylpyridin-3-yl)acetonitrile as an orange oil. Content: 83.70 (GC, o by weight), 0.340 of aldehyde). Yield: 92.70 based on 2-methyl-5-vinylpyridine.
1H-NMR (CDC13) : 1. 08 (t, 6H) ;
2.50 (m, 2H);
2.58 (s, 3H);
2.65 (m, 2H);
5.00 (s, 1H);
7.18 (d, J = 8 Hz, 1H);
7.74 (dd,J = 8 Hz, 2 Hz, 1H);
8.66 (d, J = 2 Hz, 1:H) .
Example 3c.
Preparation and characterization of the adduct of 2-methylpyridine-5-carbaldehyde with sodium hydrogen sulphite After the addition of bisulphate, the 1H- and 13C-NMR of a sample were measured. The NMR signals of the aldehyde had disappeared completely, and the following signals were observed instead:
1H-NMR (DMSO-d6): 1.96 (s, 3H);
5.01 (s, 1H) ;
6.85 (d, J = 8 Hz, 1H);
7.45 (dd, J = 8 and 2 Hz, 1H);
7. 93 (d, J = 2 Hz, 1H) .
1sC-NMR ( DMSO-d6 ) : 2 0 . 2 3 ( CH3 ) ;
81.78 (CH);
124. 14 (C-5) ;
130.02 (C-3) ;
138.76 (C-4);
143.08 (C-2);
156.04 (C-6).
Example 4a.
Preparation of 1-(6-methylpyridin-3-yl)-2-[(4-(methyl-sulfonyl)phenyl]ethanone (aqueous NaoH as base) 41.07 g (89.1%, 1.00 eq.) of N,N-diethylamino-(6-methylpyridin-3-yl)acetonitrile, 30 ml of toluene and 10.0 g of Celite were initially charged. 72 g (5 eq.) of a 50o aqueous NaOH solution were then added over a period of 15 minutes such that the temperature l0 could be maintained at 20°C. The reaction mixture was heated to 45°C. (~Iith vigorous stirring, a first portion of 0.32 g of tetra-n-butylammonium bromide was added.
Immediately after that, a solution of 0.32 g of tetra-n-butylammonium bromide and 44.52 g (1.2 eq.) of 4-(methylsulphonyl)benzyl chloride in 200 ml of toluene was added over a period of 1.5 h. After half had been added, a third 'portion of 0.32 g of tetra-n-butylammonium bromide was, added, and stirring was continued at 45°C for 6 h.
The reaction mixture was then warmed to room temperature, and 100 ml of water and 100 ml of toluene were then added. The mixture was filtered, the residue was washed with 25 ml of toluene and the phases were then separated. The aqueous phase was extracted with 2 x 50 ml of toluene. The combined organic phases were then extracted with 380 ml of 1N HCl. Neutralization with 29.6 g of 50o aqueous NaOH solution to pH 4.5 resulted in the title product crystallizing out. The suspension was filtered and the product was washed with 2 x 100 ml of water and 2 x 80 ml of isopropanol/water l:l and subsequently dried at 20°C/20 mbar.
This gave 40.19 g (76.4%) of the title product having a content of 99.Oo.
M.p. 182°C-183°C
1H-NMR (CDC13) : 9.15 (1H, s) ;
8.18 (1H, d);
7 . 92 (2H, d) ;
- 1.1 -7.47(2H, d);
7.30(1H, d);
4. (2H, s) 39 ;
3.04(3H, s);
2 ( s . 3H, ) 63 .
Example 4b.
Preparation of 1 -(6-methylpyridin-3-yl)-2-[(4-(methyl-sulfonyl)phenyl]ethanone (alkoxide, anhydrous) At 20°C, 48.16 g (84.5%, 1.00 eq.) of N,N
diethylamino-(6-methylpyridin-3-yl)acetonitrile in 20 ml of tetrahydrofuran were added over a period of 30 minutes to a suspension of 38.58 g (1.7 eq.) of potassium t-butoxide in 60 ml of tetrahydrofuran.
Immediately afterwards, 42.59 g (1.03 eq.) of 4 (methylsulphonyl)benzyl chloride in 60 ml of tetrahydrofuran were added at from 20°C to 25°C over a period of 1.5 h.
The reaction mixture was stirred at 20°C for 0.5 h and then diluted with 100 ml of water, and adjusted to pH 2 by addition of 180 ml of 2N HC1 over a period of one hour. After a further 0.5 h at 20°C, the mixture was adjusted to pH 3using 10 g of a 30o aqueous NaOH
solution. The suspension c~ias stirred at 20°C for one hour and then filtered, and the product was washed with 2 x 150 ml of water and 2 x 100 ml of water/isopropanol l:l. Drying at 20°C/20 mbar gave 53.72 g (92%) of the title product having a content of 99.1.
M.p. 182°C-183°C
1H-NMR (CDC13) : 9. 15 (1H, s) ;
8. 18 (1H, d) ;
7 . 92 (2H, d) ;
7.47 (2H; d);
7.30 (1H, d);
4.39 (2H, s);
3.04 (3H, s);
2.63 (3H, s).
Preparation of 1-(6-methylpyridin-3-yl)-2-[(4-(methyl-sulfonyl)phenyl]ethanone (aqueous NaoH as base) 41.07 g (89.1%, 1.00 eq.) of N,N-diethylamino-(6-methylpyridin-3-yl)acetonitrile, 30 ml of toluene and 10.0 g of Celite were initially charged. 72 g (5 eq.) of a 50o aqueous NaOH solution were then added over a period of 15 minutes such that the temperature l0 could be maintained at 20°C. The reaction mixture was heated to 45°C. (~Iith vigorous stirring, a first portion of 0.32 g of tetra-n-butylammonium bromide was added.
Immediately after that, a solution of 0.32 g of tetra-n-butylammonium bromide and 44.52 g (1.2 eq.) of 4-(methylsulphonyl)benzyl chloride in 200 ml of toluene was added over a period of 1.5 h. After half had been added, a third 'portion of 0.32 g of tetra-n-butylammonium bromide was, added, and stirring was continued at 45°C for 6 h.
The reaction mixture was then warmed to room temperature, and 100 ml of water and 100 ml of toluene were then added. The mixture was filtered, the residue was washed with 25 ml of toluene and the phases were then separated. The aqueous phase was extracted with 2 x 50 ml of toluene. The combined organic phases were then extracted with 380 ml of 1N HCl. Neutralization with 29.6 g of 50o aqueous NaOH solution to pH 4.5 resulted in the title product crystallizing out. The suspension was filtered and the product was washed with 2 x 100 ml of water and 2 x 80 ml of isopropanol/water l:l and subsequently dried at 20°C/20 mbar.
This gave 40.19 g (76.4%) of the title product having a content of 99.Oo.
M.p. 182°C-183°C
1H-NMR (CDC13) : 9.15 (1H, s) ;
8.18 (1H, d);
7 . 92 (2H, d) ;
- 1.1 -7.47(2H, d);
7.30(1H, d);
4. (2H, s) 39 ;
3.04(3H, s);
2 ( s . 3H, ) 63 .
Example 4b.
Preparation of 1 -(6-methylpyridin-3-yl)-2-[(4-(methyl-sulfonyl)phenyl]ethanone (alkoxide, anhydrous) At 20°C, 48.16 g (84.5%, 1.00 eq.) of N,N
diethylamino-(6-methylpyridin-3-yl)acetonitrile in 20 ml of tetrahydrofuran were added over a period of 30 minutes to a suspension of 38.58 g (1.7 eq.) of potassium t-butoxide in 60 ml of tetrahydrofuran.
Immediately afterwards, 42.59 g (1.03 eq.) of 4 (methylsulphonyl)benzyl chloride in 60 ml of tetrahydrofuran were added at from 20°C to 25°C over a period of 1.5 h.
The reaction mixture was stirred at 20°C for 0.5 h and then diluted with 100 ml of water, and adjusted to pH 2 by addition of 180 ml of 2N HC1 over a period of one hour. After a further 0.5 h at 20°C, the mixture was adjusted to pH 3using 10 g of a 30o aqueous NaOH
solution. The suspension c~ias stirred at 20°C for one hour and then filtered, and the product was washed with 2 x 150 ml of water and 2 x 100 ml of water/isopropanol l:l. Drying at 20°C/20 mbar gave 53.72 g (92%) of the title product having a content of 99.1.
M.p. 182°C-183°C
1H-NMR (CDC13) : 9. 15 (1H, s) ;
8. 18 (1H, d) ;
7 . 92 (2H, d) ;
7.47 (2H; d);
7.30 (1H, d);
4.39 (2H, s);
3.04 (3H, s);
2.63 (3H, s).
Claims (17)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone of the formula wherein 2-methyl-5-vinylpyridine is initially converted, by reaction with ozone and subsequent reduction, into 2-methylpyridine-5-carbaldehyde or into 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid or acid salt of the formula in which M is an alkali metal, which is then reacted with a dialkylamine and a cyano compound to give a N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile of the formula in which R1 and R2 are identical or different and are each C1-4-alkyl, and the acetonitrile (III) is finally reacted, in the presence of a base, with a 4-(methylsulfonyl)benzyl halide to give 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]-ethanone of the formula (I).
2. A process according to claim 1, wherein the reaction of 2-methyl-5-vinylpyridine with ozone is carried out in the presence of a mineral acid.
3. A process according to claim 2, wherein the reaction with ozone is carried out at a temperature of from -20°C to 0°C.
4. A process according to any one of claims 1 to 3, wherein the reduction is carried out using an alkali metal hydrogen sulfite, with formation of the 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt defined in claim 1.
5. A process according to claim 4, wherein the reduction is carried out at a temperature of from -20°C to 20°C.
6. A process according to claim 4 or 5, wherein the 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt is used without isolation for preparing the N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile of the formula (III).
7. A process according to any one of claims 1 to 6, wherein the cyano compound used in the reaction of the 2-methylpyridine-5-carbaldehyde is an aqueous HCN
solution or an aqueous solution of an alkali metal cyanide.
solution or an aqueous solution of an alkali metal cyanide.
8. A process according to any one of claims 1 to 7, wherein the temperature for the reaction of the 2-methylpyridine-5-carbaldehyde with the dialkylamine and the cyano compound is from 0°C to 30°C.
9. A process according to any one of claims 1 to 8, wherein the base used in the reaction of the N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile of the formula (III) is either an aqueous alkali metal hydroxide solution together with a phase-transfer catalyst or an alkali metal alkoxide in the presence of an organic solvent.
10. A process according to any one of claims 1 to 9, wherein the 2-methyl-5-vinylpyridine is obtained using 2-methyl-5-ethylpyridine as starting material.
11. A process according to claim 10, wherein the 2-methyl-5-ethylpyridine is converted at a temperature of from 500°C to 700°C in the presence of a catalyst into the 2-methyl-5-vinylpyridine.
12. A process according to claim 11, wherein the catalyst used is a silica, silica gel, iron oxide, zinc oxide, chromium oxide, copper chromite, magnesium oxide, potassium oxide, aluminum oxide or borophosphate, on its own or as a mixture, if appropriate applied to a support.
13. A process according to claim 11 or 12, wherein the reaction is carried out at a temperature of from 600°C to 700°C.
14. A 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt of the formula in which M is an alkali metal.
15. A process for preparing a 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt according to claim 14, wherein 2-methyl-5-vinylpyridine is converted, by reaction with ozone and subsequent reduction with an alkali metal hydrogen sulfite, into the end product of the formula (II).
16. A process for preparing a N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile of the formula (III) in which R1 and R2 are identical or different and are each C1-4-alkyl, wherein 2-methylpyridine-5-carbaldehyde or 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonic acid salt of the formula (II) is reacted with a dialkylamine and a cyano compound to give the end product of the formula (III).
17. A process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone of the formula wherein in a first step a), 2-methyl-5-ethylpyridine is converted at a temperature of from 500°C to 700°C
in the presence of a catalyst into 2-methyl-5-vinylpyridine, in a second step b), the 2-methyl-5-vinylpyrdine is converted by reaction with ozone and subsequent reduction into 2-methylpyridine-5-carbaldehyde, in a third step c), 2-methylpyridine-5-carbaldehyde is converted, using a dialkylamine and a cyano compound, into the corresponding N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile, and finally, in a last step d), the N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile is reacted in the presence of a base with a 4-(methylsulfonyl)benzyl halide to give 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone.
in the presence of a catalyst into 2-methyl-5-vinylpyridine, in a second step b), the 2-methyl-5-vinylpyrdine is converted by reaction with ozone and subsequent reduction into 2-methylpyridine-5-carbaldehyde, in a third step c), 2-methylpyridine-5-carbaldehyde is converted, using a dialkylamine and a cyano compound, into the corresponding N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile, and finally, in a last step d), the N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile is reacted in the presence of a base with a 4-(methylsulfonyl)benzyl halide to give 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanone.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002485739A CA2485739C (en) | 1999-01-14 | 2000-01-13 | Process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl)phenyl]ethanone |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99100590 | 1999-01-14 | ||
| EP99100590.1 | 1999-01-14 | ||
| US14599699P | 1999-07-29 | 1999-07-29 | |
| US60/145,996 | 1999-07-29 | ||
| PCT/EP2000/000240 WO2000042014A2 (en) | 1999-01-14 | 2000-01-13 | 1-(6- methylpyridine- 3-yl)-2-[4- (methylsulfonyl) phenyl] ethanone and method for its preparation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002485739A Division CA2485739C (en) | 1999-01-14 | 2000-01-13 | Process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl)phenyl]ethanone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2359958A1 CA2359958A1 (en) | 2000-07-20 |
| CA2359958C true CA2359958C (en) | 2006-04-04 |
Family
ID=34089809
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002359958A Expired - Fee Related CA2359958C (en) | 1999-01-14 | 2000-01-13 | Process for preparing 1-(6-methylpyridin-3yl)-2-[(4-methylsulfonyl)phenyl]ethanone |
| CA002485739A Expired - Fee Related CA2485739C (en) | 1999-01-14 | 2000-01-13 | Process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl)phenyl]ethanone |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002485739A Expired - Fee Related CA2485739C (en) | 1999-01-14 | 2000-01-13 | Process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl)phenyl]ethanone |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP1159270B1 (en) |
| JP (1) | JP4765167B2 (en) |
| CN (2) | CN1170820C (en) |
| AT (2) | ATE287396T1 (en) |
| AU (1) | AU2290800A (en) |
| CA (2) | CA2359958C (en) |
| CZ (1) | CZ302270B6 (en) |
| DE (2) | DE50004327D1 (en) |
| DK (2) | DK1394149T3 (en) |
| ES (2) | ES2235138T3 (en) |
| HU (1) | HUP0105124A3 (en) |
| IL (1) | IL143981A0 (en) |
| PT (2) | PT1159270E (en) |
| SK (1) | SK284903B6 (en) |
| WO (1) | WO2000042014A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104725300A (en) * | 2015-02-28 | 2015-06-24 | 宁波九胜创新医药科技有限公司 | Preparation method of 1-(6-methyl pyridine-3-yl)-2-(4-methylsulfonyl phenyl) ethanone |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313683A (en) * | 1963-04-22 | 1967-04-11 | Lilly Co Eli | Nematocidal and fungicidal methods |
| FR2074674A1 (en) * | 1970-01-16 | 1971-10-08 | Simafex | Sulphonamide/aldehyde-bisulphite complexes - antibacterials with very high solubility in water |
| US4155909A (en) * | 1977-06-13 | 1979-05-22 | Philip Morris Incorporated | 2-Alkyl nicotinoids and processes for their production |
| US5596008A (en) * | 1995-02-10 | 1997-01-21 | G. D. Searle & Co. | 3,4-Diaryl substituted pyridines for the treatment of inflammation |
| CN1152863C (en) * | 1996-07-18 | 2004-06-09 | 麦克弗罗斯特(加拿大)公司 | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| TW492959B (en) * | 1997-04-18 | 2002-07-01 | Merck & Co Inc | Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors |
| AR015938A1 (en) * | 1997-09-25 | 2001-05-30 | Merck Sharp & Dohme | PROCEDURE TO PREPARE DIARIL PIRIDINES USEFUL AS COX-2 INHIBITORS AND INTERMEDIATE COMPOUND |
| KR100414998B1 (en) * | 1998-04-24 | 2004-01-13 | 머크 앤드 캄파니 인코포레이티드 | Process for synthesizing COX-2 inhibitors |
-
2000
- 2000-01-13 AU AU22908/00A patent/AU2290800A/en not_active Abandoned
- 2000-01-13 CZ CZ20012457A patent/CZ302270B6/en not_active IP Right Cessation
- 2000-01-13 EP EP00901555A patent/EP1159270B1/en not_active Expired - Lifetime
- 2000-01-13 CA CA002359958A patent/CA2359958C/en not_active Expired - Fee Related
- 2000-01-13 HU HU0105124A patent/HUP0105124A3/en unknown
- 2000-01-13 DE DE50004327T patent/DE50004327D1/en not_active Expired - Lifetime
- 2000-01-13 PT PT00901555T patent/PT1159270E/en unknown
- 2000-01-13 SK SK972-2001A patent/SK284903B6/en not_active IP Right Cessation
- 2000-01-13 AT AT03024787T patent/ATE287396T1/en active
- 2000-01-13 ES ES03024787T patent/ES2235138T3/en not_active Expired - Lifetime
- 2000-01-13 EP EP03024787A patent/EP1394149B1/en not_active Expired - Lifetime
- 2000-01-13 DE DE50009312T patent/DE50009312D1/en not_active Expired - Lifetime
- 2000-01-13 JP JP2000593582A patent/JP4765167B2/en not_active Expired - Fee Related
- 2000-01-13 DK DK03024787T patent/DK1394149T3/en active
- 2000-01-13 CN CNB008027218A patent/CN1170820C/en not_active Expired - Fee Related
- 2000-01-13 PT PT03024787T patent/PT1394149E/en unknown
- 2000-01-13 DK DK00901555T patent/DK1159270T3/en active
- 2000-01-13 AT AT00901555T patent/ATE253559T1/en active
- 2000-01-13 WO PCT/EP2000/000240 patent/WO2000042014A2/en active Application Filing
- 2000-01-13 CA CA002485739A patent/CA2485739C/en not_active Expired - Fee Related
- 2000-01-13 CN CNB200410069946XA patent/CN1281589C/en not_active Expired - Fee Related
- 2000-01-13 ES ES00901555T patent/ES2209807T3/en not_active Expired - Lifetime
- 2000-01-13 IL IL14398100A patent/IL143981A0/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| DK1159270T3 (en) | 2004-02-23 |
| EP1159270B1 (en) | 2003-11-05 |
| ES2209807T3 (en) | 2004-07-01 |
| ES2235138T3 (en) | 2005-07-01 |
| CN1281589C (en) | 2006-10-25 |
| PT1394149E (en) | 2005-05-31 |
| JP4765167B2 (en) | 2011-09-07 |
| SK284903B6 (en) | 2006-02-02 |
| DE50009312D1 (en) | 2005-02-24 |
| EP1394149B1 (en) | 2005-01-19 |
| CN1170820C (en) | 2004-10-13 |
| PT1159270E (en) | 2004-03-31 |
| WO2000042014A2 (en) | 2000-07-20 |
| JP2003518002A (en) | 2003-06-03 |
| CA2485739C (en) | 2009-09-22 |
| CA2359958A1 (en) | 2000-07-20 |
| CN1359374A (en) | 2002-07-17 |
| SK9722001A3 (en) | 2001-12-03 |
| AU2290800A (en) | 2000-08-01 |
| EP1159270A2 (en) | 2001-12-05 |
| ATE253559T1 (en) | 2003-11-15 |
| WO2000042014A3 (en) | 2000-12-07 |
| CZ20012457A3 (en) | 2002-01-16 |
| DE50004327D1 (en) | 2003-12-11 |
| IL143981A0 (en) | 2002-04-21 |
| CA2485739A1 (en) | 2000-07-20 |
| CZ302270B6 (en) | 2011-01-19 |
| HUP0105124A3 (en) | 2002-05-28 |
| HUP0105124A2 (en) | 2002-04-29 |
| DK1394149T3 (en) | 2005-04-04 |
| ATE287396T1 (en) | 2005-02-15 |
| CN1583723A (en) | 2005-02-23 |
| EP1394149A1 (en) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7799916B2 (en) | Process for the preparation of 5-(4-[4-(5-cyano-3-indolyl)butyl]-1-piperazinyl)benzofuran-2-carboxamide | |
| EP2406235B1 (en) | Process for the preparation of bosentan | |
| TW425383B (en) | Novel Α-hydroxyl acid derivatives, their preparation and use | |
| CA2359958C (en) | Process for preparing 1-(6-methylpyridin-3yl)-2-[(4-methylsulfonyl)phenyl]ethanone | |
| CN109467536B (en) | Synthesis method of 2-chloro/hydroxypyrimidine-5-carboxylic acid | |
| US7141673B1 (en) | 1-(6-methylpyridine-3-yl)-2-[4-(methylsulphonyl) phenyl] ethanone and method for its preparation | |
| HU208533B (en) | Process for selective etherification of ascorbinic acid derivatives | |
| KR100971371B1 (en) | Process for preparing voriconazole by using new intermediates | |
| TWI282789B (en) | Process for the preparation of 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl)phenyl]ethanone | |
| JP3031279B2 (en) | Method for producing 2-alkoxy-6- (trifluoromethyl) pyrimidin-4-ol | |
| US8815870B2 (en) | 4-(2-(6-substituted-hexylidene) hydrazinyl)benzonitrile and preparation thereof | |
| KR100856133B1 (en) | Improved process for preparing atorvastatin | |
| CN110903238B (en) | Preparation method of kovar stat | |
| US20060030712A1 (en) | Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof | |
| JPH0573738B2 (en) | ||
| CN105017219A (en) | Synthetic method for p53-MDM2-binding inhibitor dyhydroxyl quinoline derivative | |
| EP2456758B1 (en) | A process for preparing trisubstituted phenyl derivatives comprising a (1h-1,2,4-triazol-1-yl)alkyl group | |
| JP4018816B2 (en) | Cycloheptenone derivative and method for producing the same, and method for producing cycloheptimidazole derivative using the same | |
| JP2000309595A (en) | Production of n-[5-(diphenylphosphinoylmethyl)-4-(4- fluorophenyl)-6-isopropylpyrimidin-2-yl-n- methylmethanesulphonamide | |
| EP2332923A1 (en) | 5-ý2-(methylthio)ethoxy¨pyrimidine-2-amine manufacturing method | |
| CN114213339A (en) | Preparation method of epidermal cell growth factor receptor mutation inhibitor | |
| IE53383B1 (en) | Chemical process | |
| BG60588B1 (en) | Method for the preparation of quinoline derivatives | |
| JPH04295468A (en) | Method of manufacturing piperazinylpyrimidine derivative | |
| NZ538325A (en) | Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20130114 |